// App-Quantinova.ai

: Detection of Clinically Relevant Molecular Alterations in Chronic Lymphocytic Leukemia (CLL) By Nanopore Sequencing

Researchers

Presenter

  • Adam Burns

Principal Investigators

  • David Robert Bruce

  • Pauline Robbe

  • Adele Timbs

  • Basile Stamatopoulos

  • Ruth Clifford

  • Maria Lopopolo

  • Duncan Parkes

  • Kate E Ridout

  • Anna Schuh

Medical Centers

  • Department of Oncology, University of Oxford, Oxford, United Kingdom

  • University of Oxford, Oxford, United Kingdom

  • Oxford Molecular Diagnostics Centre, University of Oxford, Radcliffe Department of Medicine, Oxford, United Kingdom

  • Oxford Radcliffe Hospitals NHS Trust, Oxford, UK

  • Laboratory of Clinical Cell Therapy,Institut Jules Bordet, ULB,Brussels,Belgium

  • Department of Surgery, University Hospital Limerick, Limerick, Ireland

  • The Wellcome Trust Centre For Human Genetics, University of Oxford, Oxford, United Kingdom

  • Department of Oncology, University of Oxford, Oxford, United Kingdom

  • Oxford University Hospitals NHS Trust, Oxford, United Kingdom

Locations

  • United Kingdom

  • Belgium

  • Ireland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic Lymphocytic Leukemia

Biomarkers

  • Tumor protein p53

Drug/Treatment

  • TP53

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved